2JEON Y T, PARK I A, KIM Y B, et al. Steroid receptor expres- sions in endometrial cancer: clinical significance and epidemiologi- cal implication [ J ]. Cancer Lett, 2006, 239 (2) : 198 - 204.
3ZANNONI G F, MONTEROSSI G, DE STEFANO I, et al. The expression ratios of estrogen receptor alpha (ERalpha) to estrogen receptor betal ( ERbetal ) and ERa]pha to ERbeta2 identify poor clinical outcome in endometrioid endometrial eaneer[ J ]. Hum Pathol, 2013, 44(6) : 1047 - 1054.
4JANZEN D M, ROSALES M A, PAIK D Y, et al. Progesterone receptor signaling in the microenvironment of endometr/al cancer influences its response to hormonal therapy [ J ]. Cancer Res, 2013, 73(15) : 4697 -4710.
5FRASCA F, PANDINI G, SCIACCA L, et al. The role of insulin receptors and IGF - I receptors in cancer and other diseases [ J ]. Arch Physiol Biochem, 2008, 114(1 ) : 23 -37.
6WANG C F, ZHANG G, ZHAO L J, et al. Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth[J]. PLoS One, 2013, 8(8) : e69001.
7MALAGUARNERA R, BELFIORE A. The insulin receptor: a new target for cancer therapy [ J ]. Front Endocrinol (Lausanne) , 2011, 2.- 93.
8DUK J M, AALDERS J G, FLEUREN G J, et al. CA 125: a use- ful marker in endometrial carcinoma [ J ]. Am J Obstet Gynecol, 1986, 155(5): 1097-1102.
9NILOFF J M, KLUG T L, SCHAETZL E, et al. Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endo- cervix[J]. Am J Obstet Gynecol, 1984, 148(8) : 1057 -1058.
10OTA S, SUGIYAMA T, USHIJIMA K, et al. Successful treatment of two patients with recurrent endometrial cancer by weekly paclita- xel[ J]. Cancer Lett, 2000, 160( 1 ) : 9 -12.
